MCG clinical study was presented at ESC Acute Cardiovascular Care 2018 in March 3rd, in Milan, Italy.
This study was conducted in Myanmar, where the locations of the cath-lab are very limited. MCG was compared with CAG, and it showed high sensitivity and specificity for the presence of severe CAD by CAG (≥ 75%).
By Author, it is evaluated as “MCG could be used for prompt detection of severe CAD in order to start appropriate (PCI/Optimal Medical Therapy) treatments in the emerging country such as Myanmar where less medical facilities and skills are available.”